Alveolar Macrophage Inhibition of Lung-Associated NK Activity: Involvement of Prostaglandins and Transforming Growth Factor-β₁

References

• Wiltrout R H, Herberman R B, Zhang S-R, et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol. 1985; 134: 4267–4275
   PubMed Web of Science ®Google Scholar
• Nolibá D, Poupon M F. Enhancement of pulmonary metastases induced by decreased lung natural killer activity. J Natl Cancer Inst. 1986; 77: 99–103
   PubMed Web of Science ®Google Scholar
• Woodruff M FA. The cytolytic and regulatory role of natural killer cells in experimental neoplasia. Biochim Biophys Acta. 1986; 865: 43–57
   PubMed Web of Science ®Google Scholar
• Barlozzari T, Leonhardt J, Wiltrout R H, Herberman R B, Reynolds C W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol. 1985; 134: 2783–2789
   PubMed Web of Science ®Google Scholar
• Nolibá D, Aumaitre E, Thang M N. In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double stranded polynucleotides. Cancer Res. 1985; 45: 4774–4778
   PubMed Web of Science ®Google Scholar
• Lauzon W, Yang H, Lemaire I. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics. Reg Immunol. 1991; 3: 145–150
   Google Scholar
• Herberman R B. Natural killer cells in lungs and other issues and regulation of their activity by suppressor cells. J Allergy Clin Immunol. 1986; 78: 566–570
   PubMed Web of Science ®Google Scholar
• Lauzon W, Lemaire I. Effects of biological response modifiers on lung natural killer activity. Immunopharmacol Immunotoxicol. 1991; 13: 237–250
   PubMed Web of Science ®Google Scholar
• Lemaire I. Characterization of the bronchoalveolar cellular response in experimental asbestosis: different reactions depending on the fibrogenic potential. Am Rev Respir Dis. 1985; 131: 144–145
   PubMed Web of Science ®Google Scholar
• Bordignon C, Villa F, Allavena P, et al. Inhibition of natural killer activity by human bronchoalveolar macrophages. J Immunol. 1982; 129: 587–590
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Nagai S, Izumi T. The mechanism of inhibition of alveolar macrophages on autologous blood natural killer cell activity. Chest. 1989; 95: 383–387
   PubMed Web of Science ®Google Scholar
• Lemaire I, St-Jean M. Modulation of lung-associated natural killer activity by resident and activated alveolar macrophages. Immunol Invest. 1990; 19: 27–40
   PubMed Web of Science ®Google Scholar
• Robinson B WS, Pinkston P, Crystal R G. Natural killer cells are present in the normal human lung but are functionally impotent. J Clin Invest. 1984; 74: 942–950
   PubMed Web of Science ®Google Scholar
• Weissler J C, Nicod L P, Toews G B. Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis. 1987; 135: 1353–1357
   PubMed Web of Science ®Google Scholar
• Weissman D N, deShazo R D, Banks D E. Modulation of natural killer cell function by human alveolar macrophages. J Allergy Clin Immunol. 1986; 78: 571–577
   PubMed Web of Science ®Google Scholar
• Nelson J AS, Parhar R S, Scodras J M, Lala P K. Characterization of macrophage subsets regulating murine natural killer cell activity. J Leuk Biol. 1990; 48: 382–393
   PubMed Web of Science ®Google Scholar
• Koren H S, Anderson S J, Fischer D G, Copeland C S, Jensen P J. Regulation of human natural killing, I: the role of monocytes, interferon, and prostaglandins. J Immunol. 1981; 127: 2007–2013
   PubMed Web of Science ®Google Scholar
• Seaman W E, Gindhart T D, Blackman M A, Dalal B, Talal N, Werb Z. Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen. J Clin Invest. 1982; 69: 876–888
   PubMed Web of Science ®Google Scholar
• Bloom E T, Babbitt J T, Kawakami K. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics. J Immunol. 1986; 137: 172–178
   PubMed Web of Science ®Google Scholar
• Oshimi K, Oshimi Y, Satake M, Mizoguchi H. Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes. J Exp Med. 1985; 162: 472–486
   PubMed Web of Science ®Google Scholar
• Day R, Lemaire S, Nadeau D, Keith I, Lemaire I. Changes in autacoid and neuropeptide contents of lung cells in asbestos-induced pulmonary fibrosis. Am Rev Respir Dis. 1987; 136: 908–915
   PubMed Web of Science ®Google Scholar
• Pross H F, Baines M G, Rubin P, Shragge P, Patterson M S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells, IX: the quantitation of natural killer cell activity. J Clin Immunol. 1981; 1: 51–63
   PubMed Web of Science ®Google Scholar
• Ding A, Nathan C F, Stuehr D J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol. 1988; 141: 2407–2412
   PubMed Web of Science ®Google Scholar
• Danielpour D, Dart L L, Flanders K C, Roberts A B, Sporn M B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol. 1989; 138: 79–86
   PubMed Web of Science ®Google Scholar
• Rook A H, Kehrl J H, Wakefield L M, et al. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 1986; 136: 3916–3920
   PubMed Web of Science ®Google Scholar
• Malygin A M, Meri S, Timonen T. Regulation of natural killer cell activity by transforming growth factor-β and prostaglandin E2. Scand J Immunol. 1993; 37: 71–76
   PubMed Web of Science ®Google Scholar
• Gersuk G M, Holloway J M, Chang W-C, Pattengale P K. Inhibition of human natural killer cell activity by platelet-derived growth factor. Nat Immun Cell Growth Regul. 1986; 5: 283–293
   PubMedGoogle Scholar
• Gersuk G M, Chang W-C, Patttengale P K. Inhibition of human natural killer cell activity by platelet-derived growth factor, II: membrane binding studies, effects of recombinant IFN-α and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity. J Immunol. 1988; 141: 4031–4038
   PubMed Web of Science ®Google Scholar
• Denham S, Rowland I J. Inhibition of the reactive proliferation of lymphocytes by macrophages: the role of nitric oxide. Clin Exp Immunol. 1992; 87: 157–162
   PubMed Web of Science ®Google Scholar
• Kawabe T, Isobe K-I, Hasegawa Y, Nakashima I, Shimokata K. Immuno-suppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunology 1992; 76: 72–78
   PubMed Web of Science ®Google Scholar
• Mills C D. Molecular basis of “suppressor” macrophages: arginine metabolism via the nitric oxide synthetase pathway. J Immunol. 1991; 146: 2719–2723
   PubMed Web of Science ®Google Scholar
• Beckerman K P, Rogers H W, Corbett J A, Schreiber R D, McDaniel M L, Unanue E R. Release of nitric oxide during the T cell-independent pathway of macrophage activation: its role in resistance to Listeria monocytogenes. J Immunol. 1993; 150: 888–895
   PubMed Web of Science ®Google Scholar
• Brunda M J, Herberman R B, Holden H T. Inhibition of murine natural killer cell activity by prostaglandins. J Immunol. 1980; 124: 2682–2687
   PubMed Web of Science ®Google Scholar
• Goto T, Herberman R B, Maluish A, Strong D M. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol. 1983; 130: 1350–1355
   PubMed Web of Science ®Google Scholar
• Voth R, Chmielarczyk W, Storch E, Kirchner H. Induction of natural killer cell activity in mice by injection of indomethacin. Nat Immun Cell Growth Regul. 1986; 5: 317–324
   PubMedGoogle Scholar
• Vittá-Mony I, Stancou R, Bertoglio J H. Functional consequences of cAMP accumulation in human natural killer cells: implications for IL-2 and IL-4 signal transduction. J Immunol. 1990; 145: 4272–4278
   PubMed Web of Science ®Google Scholar
• Windebank K P, Abraham R T, Powis G, Olsen R A, Barna T J, Leibson P J. Signal transduction during human natural killer cell activation: Inositol phosphate generation and regulation by cyclic AMP. J Immunol. 1988; 141: 3951–3957
   PubMed Web of Science ®Google Scholar
• Fulton A M, Chong Y C. Prostaglandin E2 receptor activity and susceptibility to natural killer cells. J Leuk Biol. 1992; 51: 176–180
   PubMed Web of Science ®Google Scholar
• Smyth M J, Strobl S L, Young H A, Ortaldo J R, Ochoa A C. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes: inhibition by transforming growth factor-β. J Immunol. 1991; 146: 3289–3297
   PubMed Web of Science ®Google Scholar
• Ortaldo J R, Mason A T, O'Shea J J, et al. Mechanistic studies of transforming growth factor-β inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions: regulation of IL-2Rβ (p75) signal transduction. J Immunol. 1991; 146: 3791–3798
   PubMed Web of Science ®Google Scholar
• Martinet Y, Bitterman P B, Mornex J-F, Grotendorst G R, Martin G R, Crystal R G. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature 1986; 319: 158–160
   PubMed Web of Science ®Google Scholar
• Nelson B J, Ralph P, Green S J, Nacy C A. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J Immunol. 1991; 146: 1849–1857
   PubMed Web of Science ®Google Scholar
• Bermudez L EM, Young L S. Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J Immunol. 1991; 146: 265–270
   PubMed Web of Science ®Google Scholar
• Cuturi M C, Anegon I, Sherman F, et al. Production of hematopoietic colony-stimulating factors by human natural killer cells. J Exp Med. 1989; 169: 569–583
   PubMed Web of Science ®Google Scholar
• Pistoia V, Zupo S, Corcione A, et al. Production of colony-stimulating activity by human natural killer cells: analysis of the conditions that influence the release and detection of colony-stimulating activity. Blood 1989; 74: 156–164
   PubMed Web of Science ®Google Scholar
• Scala G, Allavena P, Djeu J Y, et al. Human large granular lymphocytes are potent producers of interleukin-1. Nature 1984; 309: 56–59
   PubMed Web of Science ®Google Scholar
• Galli M-C, Smyth M J, Young H A, Reynolds C W, Ortaldo J R. Differential regulation of interleukin-1 gene expression in human CD3- large granular lymphocytes. Cell Immunol. 1990; 131: 184–190
   PubMed Web of Science ®Google Scholar
• Serrate S A, Schulof R S, Leondaridis L, Goldstein A L, Sztein M B. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J Immunol. 1987; 139: 2338–2343
   PubMed Web of Science ®Google Scholar
• Lorenzen J, Lewis C E, McCracken D, Horak E, Greenall M, McGee J O'D. Human tumor-associated NK cells secrete increased amounts of interferon-γ and interleukin-4. Br J Cancer 1991; 64: 457–462
   PubMed Web of Science ®Google Scholar
• Chong A S-F, Pinkard J K, Lam K S, Scuderi P, Hersh E M, Grimes W J. Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-γ and tumor necrosis factor-α. Cell Immunol. 1991; 134: 96–110
   PubMed Web of Science ®Google Scholar
• Peters P M, Ortaldo J R, Shalaby M R, et al. Natural killer-sensitive targets stimulate production of TNF-α but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol. 1986; 137: 2592–2598
   PubMed Web of Science ®Google Scholar